One mosquito protein weakens several deadly flaviviruses

The protein’s discovery could lead to treatments for Zika, dengue fever, and maybe even COVID-19.

Mosquitos aren’t just irritating — they’re also incredibly dangerous, spreading life-threatening diseases to hundreds of millions of people every year.

But now, researchers at the National Institutes of Health (NIH) have discovered a protein in mosquitoes that could help doctors treat patients with some of those same diseases — and maybe even COVID-19, too.

Fat-Covered Flaviviruses

The most well-known mosquito-borne disease — malaria — is caused by a parasite. However, several others, including Zika, West Nile, dengue, and yellow fever, are caused by flaviviruses.

One thing all flaviviruses have in common is that they have a protective coating (a “viral envelope”) made from fatty compounds called lipids.

When mosquitos dine on blood, their bodies increase production of a protein called AEG12, which helps them digest red blood cells.

But mosquitoes also make AEG12 when they get infected by flaviviruses. When AEG12 hits a virus, the protein swaps out some of its own lipids for those in the viral envelope, destabilizing the virus’s structure.

“It is as if AEG12 is hungry for the lipids that are in the virus membrane, so it gets rid of some of the lipids it has and exchanges them for the ones it really prefers,” researcher Geoffrey Mueller said in a press release.

“The protein has high affinity for viral lipids and steals them from the virus.”

Targeting the Viral Envelope

Because AEG12 strongly inhibits flaviviruses, the researchers suspect it might be useful as part of a treatment in humans, too.

But flaviviruses aren’t the only type of virus with viral envelopes — coronaviruses also have them, and in the lab, AEG12 was able to weakly inhibit those as well.

It is as if AEG12 is hungry for the lipids that are in the virus membrane.

Geoffrey Mueller

Before the protein could be used against any diseases, though, researchers will need to overcome a big problem caused by its other purpose in mosquitos: blood digestion.

AEG12 helps mosquitoes digest blood by breaking open red blood cells. That’s something we want to avoid in people, so researchers would need to find a way to tweak the protein so it only interferes with viruses and leaves blood cells alone.

If they can do that, mosquitos might shift from being strictly the cause of many life-threatening diseases to being part of the solution for them, too.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at tips@freethink.com.

Related
How intestinal viruses could help you live to be 100
People who live past age 100 have a greater diversity of bacteriophages (that is, viruses that infect bacteria) in their intestines.
Gain-of-function research is more than just tweaking risky viruses
Gain-of-function experiments in the lab can help researchers get ahead of viruses naturally gaining the ability to infect people in the wild.
Something found in bats could help us survive infections and inflammation
This protein may help bats survive viral infections and could be the springboard for new anti-inflammatory drugs.
World’s first vaccine for RSV approved in the US
The FDA has approved the world’s first vaccine for RSV, a potentially deadly viral infection that has long eluded vaccination.
Ancient viruses in the human genome can help fight cancer
Armed with a DoD grant, researchers are harnessing the genetic code of ancient viral infections to fight prostate cancer.
Up Next
Ebola prevention
Exit mobile version